ScholarIQanswers from OpenAlex & ORCID
Robin Mukherjee
ResearcherPublications, citations & collaboration network
Robin Mukherjee is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Robin Mukherjee have?
ScholarIQindexed works
Robin Mukherjee has 28 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robin Mukherjee have?
ScholarIQcitation count
Robin Mukherjee has 2,888 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Robin Mukherjee?
ScholarIQh-index
Robin Mukherjee has an h-index of 11 in OpenAlex.
What is the i10-index of Robin Mukherjee?
ScholarIQi10-index
Robin Mukherjee has an i10-index of 11 in OpenAlex.
What is the OpenAlex record for Robin Mukherjee?
ScholarIQopenalex
The OpenAlex for Robin Mukherjee is on the source record.
What are the most-cited papers on Robin Mukherjee?
ScholarIQmost cited works
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
James A. de Lemos, Michael A. Blazing, Stephen D. Wiviott, Eldrin F. Lewis, Keith A.A. Fox, Harvey D. White, Jean‐Lucien Rouleau, Terje R. Pedersen, Laura H. Gardner, Robin Mukherjee, Karen E. Ramsey, Joanne Palmisano, David W. Bilheimer, Marc A. Pfeffer, Robert M. Califf, Eugene Braunwald, for the ASTEROID Investigators
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Murray Epstein, Gordon H. Williams, Myron H. Weinberger, Andrew Lewin, Scott Krause, Robin Mukherjee, Rajiv Patni, Bruce Beckerman
Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
Bertram Pitt, Harvey D. White, José Carlos Nicolau, Felipe A. Martínez, Mihai Gheorghiade, Michael Aschermann, Dirk J. van Veldhuisen, Faı̈ez Zannad, Henry Krum, Robin Mukherjee, John Vincent
Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Bertram Pitt, George L. Bakris, Luís M. Ruilope, Lorenzo A. DiCarlo, Robin Mukherjee
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
Marc Cohen, Pierre Théroux, Steven Borzak, Martin J. Frey, Harvey D. White, W. Van Mieghem, Fred Senatore, Joy Lis, Robin Mukherjee, Kathy Harris, Frédérique Bigonzi